Abstract
Vessel calcification involves an active cellular process. However, the events by which calcification occurs in vascular endothelial cells have not been sufficiently studied. We performed experiments that evaluated the effect of osteogenic medium (OM) on alkaline phosphatase activity, signaling pathways and cell death in human umbilical vein endothelial cells (HUVEC). We found that OM emits a survival signal at the beginning of cell culture and then causes massive cell death. The formation of intracellular calcium accumulation led to complete calcification spread by alkaline phosphatase produced in stimulated cells. To better understand the signaling networks involved, we analyzed the HUVEC- and HUVEC-treated cell lysates using the Kinexus™ KPSS 1.3 phospho-site pathway screen. Our studies revealed that STAT3 Serine 727 phosphorylation is enhanced in HUVEC. Treatment with 5-aza-2-deoxycytidine led up to inhibition of calcium accumulation induced by OM. These data suggest that under calcifying conditions, STAT3 is a potential important mediator of calcium uptake in endothelial cells. Continuing research is revealing the similarities, differences and deficiencies of STAT3 activities in diverse processes including the calcification of vessels.
Keywords: Vascular calcification, STAT3, Alkaline Phosphatase, 5-aza-2'-deoxycytidine, autophagy
Current Chemical Biology
Title: Enhanced Activity of pSTAT-3 Ser-727 in Functional Endothelial Cells Under Calcifying Conditions
Volume: 4 Issue: 2
Author(s): Jorge Flavio Mendoza-Rincon, Arturo Gonzalez-Robles, Rebeca Lopez-Marure and Julio Roberto Caceres-Cortes
Affiliation:
Keywords: Vascular calcification, STAT3, Alkaline Phosphatase, 5-aza-2'-deoxycytidine, autophagy
Abstract: Vessel calcification involves an active cellular process. However, the events by which calcification occurs in vascular endothelial cells have not been sufficiently studied. We performed experiments that evaluated the effect of osteogenic medium (OM) on alkaline phosphatase activity, signaling pathways and cell death in human umbilical vein endothelial cells (HUVEC). We found that OM emits a survival signal at the beginning of cell culture and then causes massive cell death. The formation of intracellular calcium accumulation led to complete calcification spread by alkaline phosphatase produced in stimulated cells. To better understand the signaling networks involved, we analyzed the HUVEC- and HUVEC-treated cell lysates using the Kinexus™ KPSS 1.3 phospho-site pathway screen. Our studies revealed that STAT3 Serine 727 phosphorylation is enhanced in HUVEC. Treatment with 5-aza-2-deoxycytidine led up to inhibition of calcium accumulation induced by OM. These data suggest that under calcifying conditions, STAT3 is a potential important mediator of calcium uptake in endothelial cells. Continuing research is revealing the similarities, differences and deficiencies of STAT3 activities in diverse processes including the calcification of vessels.
Export Options
About this article
Cite this article as:
Flavio Mendoza-Rincon Jorge, Gonzalez-Robles Arturo, Lopez-Marure Rebeca and Roberto Caceres-Cortes Julio, Enhanced Activity of pSTAT-3 Ser-727 in Functional Endothelial Cells Under Calcifying Conditions, Current Chemical Biology 2010; 4 (2) . https://dx.doi.org/10.2174/2212796811004020133
DOI https://dx.doi.org/10.2174/2212796811004020133 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment
Current Drug Delivery Biological Effects of Curcumin and Its Role in Cancer Chemoprevention and Therapy
Anti-Cancer Agents in Medicinal Chemistry Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents
Medicinal Chemistry Targeting Ion Channels in Leukemias: A New Challenge for Treatment
Current Medicinal Chemistry The Quest for a Tumor Suppressor Gene Phenotype
Current Molecular Medicine The Role of Tumor Associated Macrophages in the Tumor Microenvironment: Mechanism and Functions
Anti-Cancer Agents in Medicinal Chemistry Hypoxia and Oxidative Stress in the Pathogenesis of Gynecological Cancers and in Therapeutical Options
Current Cancer Therapy Reviews Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Current Genomics Retinoic Acid and Iron Metabolism: A Step Towards Design of a Novel Antitubercular Drug
Current Pharmaceutical Biotechnology Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents
Current Topics in Medicinal Chemistry Physiology of Immune System: Regulation of Stem Cell Survival
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Synergy Against Fungal Pathogens: Working Together is Better Than Working Alone
Current Medicinal Chemistry Polysulfated/Sulfonated Compounds for the Development of Drugs at the Crossroad of Viral Infection and Oncogenesis
Current Pharmaceutical Design Therapeutic Antibodies
Current Molecular Medicine Strategic Aspects of NPY-Based Monoclonal Antibodies for Diagnosis and Treatment of Breast Cancer
Current Protein & Peptide Science The Mevalonate Pathway as a Therapeutic Target in the Ph-Negative Chronic Myeloproliferative Disorders
Current Drug Targets Ras-Induced Senescence and its Physiological Relevance in Cancer
Current Cancer Drug Targets Emerging Evidence for the Role of Neurotransmitters in the Modulation of T Cell Responses to Cognate Ligands
Central Nervous System Agents in Medicinal Chemistry Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
Current Cancer Drug Targets Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab
Current Medicinal Chemistry